Emergent Stands Ready

Enabling development and manufacture of COVID-19 vaccine candidates, Emergent is partnering with industry innovators providing CDMO services to prepare vaccine candidates today — confident in our ability to protect and enhance life. 

 

 

 

Perfecting Your Formula

Whether you lead a small group of inspired scientists or a global pharmaceutical powerhouse, you share a common objective: To overcome every obstacle in the way of your product's success. 

Having an experienced hand at your side can make all the difference, especially when navigating the ups and downs of advanced drug development and manufacturing. Since 1998, Emergent BioSolutions has been a trusted, go-to source for solving some of the most complex and critical challenges in public health. 

Wherever you are in your journey, whatever challenges you face, our experts and resources are ready to go to work for you. 

Let's get started with your next clinical or commercial candidate. Your new formula for success awaits.  

 

View our CDMO Services Brochure

6 min read

Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B

  • Total baseline value for Emergent is approximately $90 million USD, further expanding the collaboration between the companies, which began in February 2021

GAITHERSBURG, Md. and CALGARY, Alberta,...

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation, allowing for favorable processing of the desired therapeutic or...

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug product manufacturing processes. One of the most prevalent sources is...

Emergent CDMO Services

 

Development Services

  • Process Development
  • Analytical Development
  • Formulation Development
  • non-GMP lab-scale manufacturing

Read On

Development
 

Drug Substance Manufacturing

  • Clinical and Commercial Scale
  • Upstream and Downstream Processing
  • Single-Use Systems
  • Multiple Platform Technologies

Read On

CMO-bds_duotone_blue
 

Drug Product Manufacturing

  • Liquid and Lyophilized Products
  • Vials and Prefilled Syringes
  • Commercial Packaging: Labeling, Inspection, Distribution
  • Product and Stability Testing
  • High containment product filling capability (live viral and non-viral)

Read On

EBSI_CMO_R

Interested in Starting a Project?

If you are interested in potentially starting a project with Emergent, want to find out more information about Emergent, or would like to have us contact you for any reason, please use this web form to send us information or questions, or call us toll-free at 1-800-441-4225